Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate COVID-19 Pneumonia, Severe COVID-19 Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05665205
What this trial is testing

Benefits of an Aerobic and Strength Rehabilitation Program With Post- SARS-CoV-2 Patients Moderate-severe

Who this might be right for
COVID-19
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 20
Large-scale testing (Phase 3)Ended earlyNCT04695704
What this trial is testing

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:

Who this might be right for
Covid19SARS (Disease)
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 86
Testing effectiveness (Phase 2)Ended earlyNCT05195749
What this trial is testing

A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care

Who this might be right for
COVID-19
101 Therapeutics 3
Testing effectiveness (Phase 2)Study completedNCT04402060
What this trial is testing

APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Who this might be right for
COVIDCovid-19Coronavirus+6 more
Apellis Pharmaceuticals, Inc. 72
Testing effectiveness (Phase 2)UnknownNCT04674566
What this trial is testing

Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19

Who this might be right for
Covid19
Corat Therapeutics Gmbh 45
Testing effectiveness (Phase 2)Ended earlyNCT04458948
What this trial is testing

Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients

Who this might be right for
COVID-19
University of New Mexico 28
Testing effectiveness (Phase 2)Study completedNCT04357808
What this trial is testing

Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID)

Who this might be right for
Covid-19
Maria del Rosario Garcia de Vicuña Pinedo 30
Not applicableUnknownNCT04429711
What this trial is testing

Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Sheba Medical Center 100
Testing effectiveness (Phase 2)Ended earlyNCT04416048
What this trial is testing

Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19

Who this might be right for
COVID-19
Charite University, Berlin, Germany 111
Large-scale testing (Phase 3)UnknownNCT05056558
What this trial is testing

Efficacy and Safety of Baricitinib in Patients With Moderate and Severe COVID-19

Who this might be right for
Covid19
Incepta Pharmaceuticals Ltd 480
Not applicableStudy completedNCT04412551
What this trial is testing

Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19

Who this might be right for
Corona Virus InfectionVirus DiseasesCoronaviridae Infections
Dalarna County Council, Sweden 72
Not applicableStudy completedNCT06767241
What this trial is testing

Transcranial Non-invasive Electrical Stimulation of the Vagus Nerve in Hospitalized Moderate-to-severe COVID-19 Patients

Who this might be right for
COVID-19
University of Medicine and Pharmacy "Victor Babes" Timisoara 83
Testing effectiveness (Phase 2)UnknownNCT04780685
What this trial is testing

A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19

Who this might be right for
Covid19
Stemedica Cell Technologies, Inc. 40
Large-scale testing (Phase 3)UnknownNCT05096052
What this trial is testing

PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19

Who this might be right for
COVID-19COVID-19 PandemicCOVID-19 Respiratory Infection+2 more
Bioxytran Inc. 408
Post-approval studies (Phase 4)UnknownNCT04359316
What this trial is testing

Azithromycin in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Testing effectiveness (Phase 2)UnknownNCT04902183
What this trial is testing

Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19

Who this might be right for
Covid19
Athens Medical Society 90
Testing effectiveness (Phase 2)UnknownNCT04622865
What this trial is testing

Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19

Who this might be right for
SARS-CoV 2COVID-19Coronavirus Disease 2019
AB Science 200
Testing effectiveness (Phase 2)UnknownNCT04869579
What this trial is testing

Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.

Who this might be right for
Covid19
CHRISTUS Health 100
Testing effectiveness (Phase 2)Study completedNCT04419025
What this trial is testing

Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease

Who this might be right for
COVIDSars-CoV2SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere+1 more
Cambridge Health Alliance 165
Testing effectiveness (Phase 2)WithdrawnNCT05085574
What this trial is testing

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

Who this might be right for
2019 Novel Coronavirus Disease2019 Novel Coronavirus Infection2019-nCoV Disease+9 more
Leidos Life Sciences
Next Page